MYOPATHY ADVERSE DRUG REACTION ASSOCIATED WITH LANSOPRAZOLE: A CASE REPORT
Abstract
Proton pump inhibitor has been reported to cause myopathic adverse drug reactions in several
overseas countries. Unfortunately, this case has never been raised and has not received much attention
in Indonesia. A case about myopathy associated with lansoprazole in 48-years old man has been recently reported
in Indonesia. Assessment methods used were time series data collection followed by causality analysis
using Naranjo Scale. The results of analysis revealed a Naranjo Scale of 9, which was interpreted as definite.
This report concluded that lansoprazole could triggered myopathy adverse drug reaction in some sensitive
patient. The mechanism presumably through inhibition of H+K+-ATPase in other tissue which can lead
destruction of myofibril and leakage of calcium, pottasium, phosphate, myoglobin, creatine phosphokinase,
lactate dehydrogenase, and aspartate transaminases from the muscle. This case report aims to remind
health professionals to pay more attention at possible myopathy adverse drug reactions in the use of lansoprazole
and other proton pump inhibitors, so that more serious adverse drug reactions could be prevented.
Downloads
Articles published in MPI are licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA) license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and MPI, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.
Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to MPI to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.
By publishing in MPI, authors grant any third party the right to use their article to the extent provided by the CC BY-SA license.